Related Experiment Videos
Angiosarcoma of soft tissue: a study of 80 cases
J M Meis-Kindblom1, L G Kindblom
1Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC, USA.
The American Journal of Surgical Pathology
|June 18, 1998
Summary
Soft tissue angiosarcoma is a high-grade sarcoma with diverse features. Prognosis is poorer with older age, retroperitoneal location, larger size, and high MIB1 proliferation.
Area of Science:
- Oncology
- Pathology
- Surgical Pathology
Background:
- Soft tissue angiosarcomas (STAS) exhibit poorly defined clinicopathologic, immunohistochemical, and ultrastructural features.
- Understanding these features is crucial for accurate diagnosis and prognosis.
Purpose of the Study:
- To comprehensively characterize the clinicopathologic, immunohistochemical, and ultrastructural features of STAS.
- To identify prognostic factors associated with patient outcomes.
Main Methods:
- Retrospective analysis of 80 STAS cases.
- Histopathological, immunohistochemical (Factor VIII-related antigen, vimentin, CD34, BNH9, cytokeratins, alpha-smooth muscle actin, Ki67/MIB1, p53), and ultrastructural evaluations.
- Clinical follow-up data analysis.
Main Results:
- STAS occurred in diverse locations, most commonly extremities and retroperitoneum, with epithelioid morphology being frequent.
- Immunohistochemistry showed positivity for Factor VIII-related antigen, vimentin, and CD34 in most cases.
- High MIB1 proliferation (>10%), older age, retroperitoneal location, and larger tumor size correlated with a poorer prognosis, with 53% mortality at a median of 11 months.
Conclusions:
- STAS is a high-grade sarcoma with significant morphologic variability.
- Key prognostic indicators include patient age, tumor site and size, and proliferative activity (MIB1).
- Accurate characterization aids in predicting outcomes and guiding treatment strategies.